Evidence map›Paper›PMID 35066652›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Prognostic analysis and nomogram establishment in patients with head and neck myoepithelial carcinoma.

Keyuan Liu, Chen Lin, Zhujun Xu, Linkun Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Predictive Modeling of Clinical Efficacy forCancer management and research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Keyuan Liu *School of Clinical Stomatology, Tianjin Medical University, Tianjin, China.
Chen Lin *School of Clinical Stomatology, Tianjin Medical University, Tianjin, China.
Zhujun XuSchool of Clinical Stomatology, Nankai University, Tianjin, China.
Linkun ZhangDepartment of Orthodontics, School of Medicine, Tianjin Stomatological Hospital, Nankai University, 75 Dagu Road, Heping District, Tianjin, China. linkunzhang@nankai.edu.cn.ORCID http://orcid.org/0000-0003-3226-4476

Funding

the 13th Five Years Clinical Key Disciplines of Tianjin ZDPY-12the Key projects of Science and Technology Fund supported by Tianjin Municipal Health and Health Committee 14KG132the Key projects of Science and Technology Fund supported by Tianjin Municipal Health and Health Committee 15KG132the National Clinical Key Specialty Construction Projects ZDZK11
6 · The paper itself

Abstract

purposeTo further explore the clinicopathological characteristics and determinants of survival of patients with HNMC.

methodsThe Surveillance, Epidemiology and End Results (SEER) database was used to collect the data of patients diagnosed with HNMC from 1975 to 2016. Kaplan-Meier analysis and log-rank testing compared the survival difference. Cox hazard regression models analyzed the survival outcome and prognostic factors. Concordance index (C-index) verified the nomogram.

resultsA total of 322 eligible cases were retrieved. The mean age at diagnosis was 61 years old and the male to female ratio was 1:1. The major salivary gland was the most common primary site (72.5%). Patients with adjuvant radiation showed better overall survival (OS) (P < 0.05). Advanced grade, N, M stage and nonsurgery contributed independently to shorter OS, while the advanced N, M stage and nonsurgery contributed independently to shorter disease-specific survival (DSS) (P < 0.05). The C-index of OS-specific nomogram was 0.768 (95% CI 0.726-0.810).

conclusionsHNMC usually appears in elderly patients and has no gender difference. The 5-year OS and DSS rates are 70% and 79.8%, respectively. Grade, N, M stage and surgery are independent prognostic factors for OS, while N, M stage and surgery are independent prognostic factors for DSS. Compared with the surgery alone, adjuvant radiation appears to offer a significant OS benefit for patients with stage III or IV.

Indexed as

CarcinomaHead and Neck NeoplasmsAgedFemaleHumansMaleMiddle AgedNomogramsPrognosisSEER ProgramHead and neckMyoepithelial carcinomaPrognosisSEER database

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.